| Bioactivity | HCV-IN-35 (Compound (R)-3h) is a potent inhibitor of HCV. HCV-IN-35 has the potential for the research infection diseases[1]. |
| Target | EC50: 0.010 ± 0.004 μM (HCV) |
| Name | HCV-IN-35 |
| CAS | 2757963-82-7 |
| Formula | C30H36ClN5 |
| Molar Mass | 502.09 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65(3):2107-2121. |
HCV-IN-35
CAS: 2757963-82-7 F: C30H36ClN5 W: 502.09
HCV-IN-35 (Compound (R)-3h) is a potent inhibitor of HCV. HCV-IN-35 has the potential for the research infection disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.